Intelligent Bio Solutions Files 8-K

Ticker: INBS · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1725430

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

IBSI filed an 8-K on 3/20/25 with Reg FD disclosures and financials.

AI Summary

Intelligent Bio Solutions Inc. filed an 8-K on March 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York City.

Why It Matters

This filing provides important updates and financial information for Intelligent Bio Solutions Inc., which could impact investor decisions.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

What was Intelligent Bio Solutions Inc. formerly known as?

Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on March 20, 2025.

Where are the principal executive offices of Intelligent Bio Solutions Inc. located?

The principal executive offices of Intelligent Bio Solutions Inc. are located at 135 West 41st Street, 5th Floor, New York, NY 10036.

In which state is Intelligent Bio Solutions Inc. incorporated?

Intelligent Bio Solutions Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing